No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Aster DM Healthcare Limited provides a broad spectrum of healthcare and associated services throughout various regions, including India, the United Arab Emirates, Qatar, Oman, the Kingdom of Saudi Arabia, Jordan, Kuwait, Bahrain, and the Republic of Mauritius. The company organizes its operations across key segments: Hospitals, Clinics, Retail Pharmacies, and other related ventures. Its facilities include hospitals with integrated in-house pharmacies, as well as clinics that also house pharmacies. Beyond these, it manages a network of retail pharmacies and optical outlets. Moreover, Aster DM Healthcare extends its offerings to include healthcare consultancy and other professional services. Founded in 1987, the enterprise maintains its headquarters in Dubai, United Arab Emirates.
www.asterdmhealthcare.comNo one on the platform currently holds ASTERDM.BO.
No tracked institution reports a position in ASTERDM.BO as of their last filing.
No one on the platform has traded ASTERDM.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.5% | 7.5% | 7.2% | — | — | — |
| Rev. Growth % | 14.1% | -11.4% | ||||
| Profit Margin % | 8.4% | 32.7% | 17.9% | |||
| Free Cash Flow Margin % | 4.3% | 5.9% | 4.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $103.8B | +124.4% | $13.73 | $9.94–$17.02 | — | 10 |
| 2028 | $130.0B | +25.3% | $19.18 | $15.89–$23.26 | — | 10 |
| 2029 | $154.3B | +18.6% | $24.10 | $22.39–$25.91 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $2.30 | $1.40 | -39.1% |
| 2026-04-30 | $1.60 | $2.70 | +68.8% |
| 2026-01-30 | $2.00 | $1.10 | -45.0% |
| 2025-10-21 | $2.20 | $2.10 | -4.5% |
| 2025-07-30 | $1.65 | $1.70 | +3.0% |
| 2025-05-20 | $1.80 | $1.80 | +0.0% |
| 2025-01-31 | $1.90 | $1.35 | -28.9% |
| 2024-10-23 | $1.60 | $1.94 | +21.2% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ASTERDM.BOAster DM Healthcare Limited | $749.35 | -2.00% | $386.3B | — |
| GLAND.BOGland Pharma Limited | $2885.00 | -1.54% | $475.6B | — |
| GLAND.NSGland Pharma Limited | $2888.40 | -1.16% | $476.5B | — |
| IPCALAB.BOIpca Laboratories Limited | $1954.50 | -0.64% | $499.5B | — |
| IPCALAB.NSIpca Laboratories Limited |
| $1953.10 |
| -0.78% |
| $495.5B |
| — |
| KIMS.BOKrishna Institute of Medical Sciences Limited | $766.00 | -0.11% | $306.0B | — |
| KIMS.NSKrishna Institute of Medical Sciences Limited | $767.30 | -0.21% | $307.0B | — |
Source: Financial Modeling Prep · peers by sector/industry